4Filed Sep 14, 8:00 PM ET
PACS Group (PACS) 10% Owner Mark Hancock Sells 300,000 Shares
$PACS · PACS Group, Inc.Research Summary
AI-generated summary of this SEC filing
PACS Group (PACS) 10% Owner Mark Hancock Sells 300,000 Shares
What Happened
Mark Hancock, a reported 10% owner of PACS Group, sold a total of 300,000 shares in open‑market transactions on September 14–15, 2026. The sales were executed in five tranches: 137,684 shares @ $44.56 ($6,134,951) and 6,634 shares @ $44.91 ($297,901) on 9/14; and 104,132 shares @ $42.09 ($4,382,989), 30,466 shares @ $42.89 ($1,306,647), and 21,084 shares @ $43.75 ($922,393) on 9/15. Total gross proceeds across all sales were $13,044,881. These disposals were effected pursuant to a Rule 10b5‑1 trading plan adopted March 11, 2026 (see footnote F1).
Key Details
- Dates: Sept 14–15, 2026; Form 4 filed 2026-09-15. No indication in the provided excerpt that the filing was late.
- Tranches and reported weighted-average prices / proceeds:
- 9/14: 137,684 sh @ $44.56 — $6,134,951 (price range reported F2: $43.885–$44.8845)
- 9/14: 6,634 sh @ $44.91 — $297,901 (price range reported F3: $44.885–$45.13)
- 9/15: 104,132 sh @ $42.09 — $4,382,989 (price range reported F4: $41.47–$42.465)
- 9/15: 30,466 sh @ $42.89 — $1,306,647 (price range reported F5: $42.47–$43.4628)
- 9/15: 21,084 sh @ $43.75 — $922,393 (price range reported F6: $43.51–$44.435)
- Total sold: 300,000 shares for $13,044,881. Weighted-average prices reported; per-price breakdowns are available from the filer on request (per footnotes).
- Shares owned after the transaction: not provided in the information supplied here — consult the filed Form 4 for post‑transaction holdings.
Context
- Hancock is a 10% owner (large shareholder), not necessarily a company officer; sales under a Rule 10b5‑1 plan typically reflect pre‑arranged dispositions rather than active timing decisions.
- Sales are often routine and generally less informative than purchases as a bullish signal; these were disposals rather than acquisitions.
- For full details (exact per-trade prices, post‑transaction holdings, and the 10b5‑1 plan terms), review the complete Form 4 (Accession: 0002014361-26-000035).